RT Journal Article
SR Electronic
T1 Causes of Death and Comorbidities in Patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.15.20131540
DO 10.1101/2020.06.15.20131540
A1 Elezkurtaj, Sefer
A1 Greuel, Selina
A1 Ihlow, Jana
A1 Michaelis, Edward
A1 Bischoff, Philip
A1 Kunze, Catarina Alisa
A1 Sinn, Bruno Valentin
A1 Gerhold, Manuela
A1 Hauptmann, Kathrin
A1 Ingold-Heppner, Barbara
A1 Miller, Florian
A1 Herbst, Hermann
A1 Corman, Victor Max
A1 Martin, Hubert
A1 Radbruch, Helena
A1 Heppner, Frank L.
A1 Horst, David
YR 2020
UL http://medrxiv.org/content/early/2020/06/17/2020.06.15.20131540.abstract
AB Infection by the new corona virus strain SARS-CoV-2 and its related syndrome COVID-19 has caused several hundreds of thousands of deaths worldwide. Patients of higher age and with preexisting chronic health conditions are at an increased risk of fatal disease outcome. However, detailed information on causes of death and the contribution of comorbidities to death yet is missing. Here, we report autopsy findings on causes of death and comorbidities of 26 decedents that had clinically presented with severe COVID-19. We found that septic shock and multi organ failure was the most common immediate cause of death, often due to suppurative pulmonary infection. Respiratory failure due to diffuse alveolar damage presented as the most immediate cause of death in fewer cases. Several comorbidities, such as hypertension, ischemic heart disease, and obesity were present in the vast majority of patients. Our findings reveal that causes of death were directly related to COVID-19 in the majority of decedents, while they appear not to be an immediate result of preexisting health conditions and comorbidities. We therefore suggest that the majority of patients had died of COVID-19 with only contributory implications of preexisting health conditions to the mechanism of death.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics board of the Charite - Universitaetsmedizin BerlinAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant information is included in the manuscript. Additonal data is available from the correspondig author upon reasonable request.